172 results on '"Guillot, Pascale V."'
Search Results
2. Induced pluripotent stem cells derived from amniotic fluid stem cells
3. Contributors
4. Publisher Correction: Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A
5. Small extracellular vesicles secreted from human amniotic fluid mesenchymal stromal cells possess cardioprotective and promigratory potential
6. Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A
7. Improving the quality of life for people with brittle bone disease: Osteogenesis Imperfecta
8. The presence of human mesenchymal stem cells of renal origin in amniotic fluid increases with gestational time
9. Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties
10. Unravelling the Pluripotency Paradox in Fetal and Placental Mesenchymal Stem Cells: Oct-4 Expression and the Case of the Emperor’s New Clothes
11. Principles of Stem Cell Biology
12. List of Contributors
13. Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice
14. 5′ isomiR variation is of functional and evolutionary importance
15. Building bones using stem cells and gene therapy
16. Placenta as a reservoir of stem cells: an underutilized resource?
17. Stem Cells Differentiation
18. Fetal Mesenchymal Stem Cells are More Primitive than Adult Mesenchymal Stem Cells
19. Comparative osteogenic transcription profiling of various fetal and adult mesenchymal stem cell sources
20. A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells
21. Stem cell differentiation and expansion for clinical applications of tissue engineering
22. Fetal Stem Cells: Betwixt and Between
23. Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach
24. Fixation-induced redistribution of hyperphosphorylated RNA polymerase II in the nucleus of human cells
25. A vascular bed-specific pathway regulates cardiac expression of endothelial nitric oxide synthase
26. Micro-computed tomography reconstructions of tibiae of stem cell transplanted osteogenesis imperfecta mice
27. Third Trimester Amniotic Fluid Harbors Mesenchymal Stem Cells of Renal Origin
28. Embryonic Stem Cell-Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic-Ischemic Mouse Brain
29. Neuroprotection of the hypoxic-ischemic mouse brain by human CD117+CD90+CD105+ amniotic fluid stem cells
30. Characterization of the Mouse von Willebrand Factor Promoter
31. TGFβ-induced osteogenic potential of human amniotic fluid stem cells via CD73-generated adenosine production
32. Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency
33. Counteracting bone fragility with human amniotic mesenchymal stem cells
34. Human Chorionic Stem Cells: Podocyte Differentiation and Potential for the Treatment of Alport Syndrome
35. Induced pluripotent stem (iPS) cells from human fetal stem cells
36. Corrigendum: In utero therapy for congenital disorders using amniotic fluid stem cells
37. Immune Regulatory Properties of CD117pos Amniotic Fluid Stem Cells Vary According to Gestational Age
38. In utero therapy for congenital disorders using amniotic fluid stem cells
39. Trisomy 21 Mid-Trimester Amniotic Fluid Induced Pluripotent Stem Cells Maintain Genetic Signatures During Reprogramming: Implications for Disease Modeling and Cryobanking
40. CD117+ amniotic fluid stem cells vary their immune regulatory properties according to gestational age
41. Stem Cell Therapy for Neonatal Brain Injury
42. Human Fetal and Adult Bone Marrow-Derived Mesenchymal Stem Cells Use Different Signaling Pathways for the Initiation of Chondrogenesis
43. Potential of Human Fetal Chorionic Stem Cells for the Treatment of Osteogenesis Imperfecta
44. Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs)
45. Human Mid-Trimester Amniotic Fluid Stem Cells Cultured Under Embryonic Stem Cell Conditions with Valproic Acid Acquire Pluripotent Characteristics
46. Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach
47. Ontological Differences in First Compared to Third Trimester Human Fetal Placental Chorionic Stem Cells
48. Reprogramming human amniotic fluid stem cells to functional pluripotency by manipulation of culture conditions.
49. Unravelling the Pluripotency Paradox in Fetal and Placental Mesenchymal Stem Cells: Oct-4 Expression and the Case of the Emperor’s New Clothes
50. Upregulating CXCR4 in Human Fetal Mesenchymal Stem Cells Enhances Engraftment and Bone Mechanics in a Mouse Model of Osteogenesis Imperfecta
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.